Assessment of myocardial viability

Seminars in Nuclear Medicine

Volumn 35, Issue 1, 2005, Pages 2-16

  Travin, Mark I ^a   Bergmann, Steven R ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RUBIDIUM 82; TETROFOSMIN TC 99M; THALLIUM 201; TRACER;

CELL FUNCTION; CELL VIABILITY; CLINICAL PROTOCOL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; ENERGY; EXERCISE TEST; FREQUENCY ANALYSIS; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART TRANSPLANTATION; HEART VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; LIFESTYLE; MEDICAL INFORMATION; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATIENT CARE; PATIENT REFERRAL; POPULATION; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; REVIEW; SCAR; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; SURVIVAL; WELLBEING;

EID: 11844254826     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2004.09.001     Document Type: Article

References (118)

1. M. Gheorgiade, R.O. Bonow Chronic heart failure in the United States. A manifestation of coronary artery disease Circulation 97 1998 282 289
2. W.T. Abraham, M.R. Bristow Specialized centers for heart failure management Circulation 96 1997 2755 2757
3. The SOLVD investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 1991 293 302
4. B. Pitt, P.A. Poole-Wilson, R. Segal Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure Randomized trial--The Losartan Heart Failure Study ELITE II Lancet 355 2000 1582 1587
5. J.N. Cohn, D.G. Archibald, S. Ziesche Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study N Engl J Med 314 1986 1547 1552
6. M. Packer, M.B. Fowler, E.B. Roecker Effect of carvedilol on the morbidity of patients with severe chronic heart failure Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study Circulation 106 2002 2194 2199
7. B. Pitt, F. Zannad, W.J. Remme randomized aldactone evaluation study investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
8. W.S. Colucci, U. Elkayam, D.P. Horton Nesiritide Study Group Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure N Engl J Med 343 2000 246 253
9. W.T. Abraham, D.L. Hayes Cardiac resynchronization therapy for heart failure Circulation 108 2003 2596 2603
10. P.C. Deedwania The key to unraveling the mystery of mortality in heart failure. An integrated approach Circulation 107 2003 1719 1721
11. V. Dilsizian Myocardial viability Reversible left ventricular dysfunction V. Dilsizian J. Narula E. Braunwald Atlas of Nuclear Cardiology 2003 Current Medicine Philadelphia, PA 19 46
12. R.A. Kloner, R. Bolli, E. Marban Medical and cellular implications of stunning, hibernation, and preconditioning. An NHLBI workshop Circulation 97 1998 1848 1867
13. E.J. Topol, J.L. Weiss, J.A. Brinker Regional wall motion improvement after coronary thrombolysis with recombinant tissue plasminogen activator Importance of coronary angioplasty J Am Coll Cardiol 6 1985 426 433
14. M. Schwaiger, U. Schricke Hibernating and stunned myocardium. Pathophysiological considerations A.E. Iskandrian E.E. Van Der Wall Myocardial Viability ed 2 2000 Kluwer Academic Publishers Dordrecht, Boston, London 1 20
15. S.H. Rahimtoola The hibernating myocardium Am Heart J 117 1989 211 221
16. S. Rahimtoola Coronary bypass surgery for chronic angina--1981 A perspective Circulation 65 1982 225 241
17. J.M. Canty Jr, J.A. Fallavolita Resting myocardial flow in hibernating myocardium Validating animal models of human pathophysiology Am J Physiol 276 1999 H417 (abstract)
18. J.L.J. Vanoverschelde, W. Wijins, C. Depre Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium Circulation 87 1993 1513 1523
19. J.J. Bax, F.F. Wahba, E.E. Van Der Waal Myocardial viability/hibernation A.E. Iskandrian M.S. Verani Nuclear Cardiac Imaging 2003 Oxford University Press New York 386 398
20. R.R. Baliga, J. Schaper, J.P. Narula Role of apoptosis in myocardial hibernation and myocardial stunning A.E. Iskandrian E.E. Van Der Wall Myocardial Viability ed 2 2000 Kluwer Academic Publishers Dordrecht, Boston, London 21 45
21. E.T.S. Lim, A. Lahiri Should we be screening for myocardial hibernation in heart failure? J Nucl Cardiol 11 2004 114 117
22. J.G. Cleland, D.J. Pennell, S.G. Ray Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial) Randomised controlled trial Lancet 362 2003 14 21
23. M. DiCarli Assessment of myocardial viability after myocardial infarction J Nucl Cardiol 9 2002 229 235
24. R.S. Beanlands, P.J. Hendry, R.G. Masters Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging Circulation 98 1998 1151 1156
25. M. Emond, M. Mock, K. Davis Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry Circulation 90 1994 2645 2657
26. G. Gioia, E. Milan, R. Giubbini Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction J Nucl Cardiol 3 1996 150 156
27. M.F. DiCarli, M. Davidson, R. Little Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction Am J Cardiol 73 1994 527 533
28. K.C. Allman, L.J. Shaw, R. Hachamovitch Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction A meta-analysis J Am Coll Cardiol 39 2002 1151 1158
29. F. Haas, C.J. Haehnel, W. Picker Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease J Am Coll Cardiol 30 1997 1693 1700
30. J.J. Bax, D. Poldermans, A. Elhendy Sensitivity, specificity, and predictive accuracy of various noninvasive techniques for detecting hibernating myocardium Curr Probl Cardiol 26 2001 141 188
31. E. Lebowitz, M.W. Greene, R. Fairchild Thallium-201 for medical use. I J Nucl Med 16 1975 151 155
32. G.M. Pohost, L.M. Zir, R.H. Moore Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201 Circulation 55 1977 294 302
33. J. Gutman, D.S. Berman, M. Freeman Time to completed redistribution of thallium-201 in exercise myocardial scintigraphy Relationship to the degree of coronary artery stenosis Am Heart J 106 1983 989 995
34. H. Kiat, D.S. Berman, J. Maddahi Late reversibility of tomographic myocardial thallium-201 defects an accurate marker of myocardial viability J Am Coll Cardiol 12 1988 1456 1463
35. P. Liu, M.C. Kiess, R.D. Okada The persistent defect on exercise thallium imaging and its fate after myocardial revascularization Does it represent scar or ischemia? Am Heart J 110 1985 996 1001
36. R.S. Gibson, D.D. Watson, G.J. Taylor Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy J Am Coll Cardiol 1 1983 804 815
37. J. Tillisch, R. Brunken, R. Marshall Reversibility of cardiac wall-motion abnormalities predicted by positron tomography N Engl J Med 314 1986 884 888
38. R. Brunken, M. Schwaiger, M. Grover-McKay Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects J Am Coll Cardiol 10 1987 557 567
39. V. Dilsizian, T.P. Rocco, N.M.T. Freedman Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging N Engl J Med 323 1990 141 146
40. 18F-fluorodeoxyglucose Circulation 83 1991 26 37
41. B.C. Berger, D.D. Watson, L.R. Burwell Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery Circulation 60 1979 1114 1125
42. A.S. Iskandrian, A. Hakki, S.A. Kane Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary arterial bypass grafting Am J Cardiol 51 1983 1312 1316
43. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function Circulation 87 1993 1630 1641
44. P.R. Pagley, G.A. Beller, D.D. Watson Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability Circulation 96 1997 793 800
45. R. Sciagrà, G. Bisi, G.M. Santoro Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting post-revascularization recovery J Am Coll Cardiol 30 1997 384 391
46. A.N. Kitsiou, G. Srinivasan, A.A. Quyyumi Stress-induced reversible and mild-moderate irreversible thallium defects Are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation 98 1998 501 508
47. Klocke FJ, Baird MG, Bateman TM,, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Radionuclide Imaging). (2003). American College of Cardiology Web Site. Available at http://www.acc.org/clinical/guidelines/radio/rni_fulltext.pdf ; Internet; accessed September 30, 2004
48. R. Taillefer, E.G. DePuey, J.E. Udelson Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-Gated SPECT) in detecting coronary artery disease in women J Am Coll Cardiol 29 1997 69 77
49. D.D. Miller The growing flood of technetium-99m myocardial perfusion agents. More water... or more mud? Circulation 91 1995 555 558
50. M.C. Cohen A snapshot of nuclear cardiology in the United States Am Soc Nucl Cardiol Newsletter 5 1998 13
51. A. Cuocolo, L. Pace, B. Ricciardelli Identification of viable myocardium in patients with chronic coronary artery disease Comparison of thallium-201 scintigraphy with reinjection and technetium-99m methoxyisobutyl isonitrile J Nucl Med 33 1992 505 511
52. P. Marzullo, G. Sambuceti, O. Parodi The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability J Nucl Med 33 1992 1925 1930
53. C. Marcassa, M. Galli, A. Cuocolo Rest-redistribution thallium-201 and rest technetium-99m-sestamibi SPECT in patients with stable coronary artery disease and ventricular dysfunction J Nucl Med 38 1997 419 424
54. 99mTc-sestamibi Circulation 89 1994 2552 2561
55. G.J. Kauffman, T.S. Boyne, D.D. Watson Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction J Am Coll Cardiol 27 1996 1592 1597
56. 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathologic study Circulation 94 1996 1010 1017
57. A.F. Maes, M. Borgers, W. Flameng Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT J Am Coll Cardiol 29 1997 62 68
58. H.J. Siebelink, P.K. Blanksma, H.J.G.M. Crijns No difference in cardiac event-free survival between positron emission tomography-guided single-photon emission computed tomography-guided patient management J Am Coll Cardiol 37 2001 81 88
59. J.E. Udelson Testing our tests Surrogate end points versus driving patient management and outcomes J Am Coll Cardiol 37 2001 89 92
60. 201Tl single-photon emission computed tomography Circulation 100 1999 1964 1970
61. V. Dilsizian, T.P. Rocco, H.W. Strauss Technetium-99m isonitrile myocardial uptake at rest. I. Relation to severity of coronary artery stenosis J Am Coll Cardiol 14 1989 1673 1677
62. M.V. Cohen, E.H. Sonnenblick, E.S. Kirk Comparative effects of nitroglycerin and isosorbide dinitrate on coronary collateral vessels and ischemic myocardium in dogs Am J Cardiol 37 1976 244 249
63. M. Aoki, K. Sakai, S. Koyanagi Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography Am Heart J 121 1991 1361 1366
64. Z.-X. He, J. Darcourt, A. Guigner Nitrates improve detection of ischemic but viable myocardium by thallium-201 reinjection SPECT J Nucl Med 34 1993 1472 1477
65. G. Bisi, R. Sciagrà, G.M. Santoro Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates feasibility and reliability for prediction of post-revascularization outcome of asynergic territories J Am Coll Cardiol 24 1994 1282 1289
66. M.G. Levine, C.C. McGill, A.W. Ahlberg Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization Am J Cardiol 83 1999 1 5
67. A.E. Iskandrian, E. Acio Methodology of a novel myocardial viability protocol J Nucl Cardiol 5 1998 206 209
68. M.I. Travin, S.D. Herman, D.G. Wolinsky Assessment of myocardial viability with gated SPECT Tc-99m sestamibi imaging during administration of sublingual nitroglycerin J Nucl Med 36 1995 56P (abstract)
69. M. Leoncini, G. Marcucci, R. Sciagrà Nitrate-enhanced gated technetium 99m sestamibi SPECT for evaluating regional wall motion at baseline and during low-dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction comparison with two-dimensional echocardiography J Nucl Cardiol 7 2000 426 431
70. I. Matsunari, S. Fujino, J. Taki Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization comparison with rest-redistribution thallium-201 J Am Coll Cardiol 29 1997 1226 1233
71. M.G. Gunning, C. Anagnostopoulos, C.J. Knight Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium Circulation 98 1998 1869 1874
72. W. He, W. Acampa, C. Mainolfi Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction relation to metabolic imaging by PET J Nucl Cardiol 10 2003 599 606
73. 99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction additional value of gated SPECT J Nucl Med 40 1999 1824 1831
74. S.R. Bergmann Cardiac positron emission tomography Semin Nucl Med 28 1998 320 340
75. 15O Circulation 70 1984 724 733
76. S.R. Bergmann Quantification of myocardial perfusion with positron emission tomography S.R. Bergmann B.E. Sobel Positron Emission Tomography of the Heart 1992 Futura Publishing, Inc Mount Kisco, New York 97 127
77. P. Herrero, A. Staudenherz, J.F. Walsh Heterogeneity of myocardial perfusion provides the physiological basis of perfusable tissue index J Nucl Med 36 1995 320 327
78. H. Iida, C.G. Rhodes, R. de Silva Myocardial tissue fraction-correction for partial volume effects and measure of tissue viability J Nucl Med 32 1991 2169 2175
79. R. De Silva, Y. Yamamoto, C.G. Rhodes Preoperative prediction of the outcome of coronary revascularization using positron emission tomography Circulation 86 1992 1738 1742
80. 15O-water and dynamic positron emission tomography Circulation 86 1992 167 178
81. P. Herrero, J. Markham, M.E. Shelton Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography Circ Res 70 1992 496 507
82. K.L. Gould, K. Yoshida, M.J. Hess Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET J Nucl Med 32 1991 1 9
83. P. Camici, E. Ferrannini, L.H. Opie Myocardial metabolism in ischemic heart disease Basic principles and application to imaging by positron emission tomography Prog Cardiovas Dis 32 1989 217 238
84. R.A. Lerch, S.R. Bergmann, B.E. Sobel Delineation of myocardial fatty acid metabolism with positron emission tomography S.R. Bergmann B.E. Sobel Positron Emission Tomography of the Heart 1992 Futura Publishing, Inc Mount Kisco, New York 129 152
85. N. Tamaki, K. Morita, E. Tsukamoto, Y. Kawai Future aspects of BMIPP Int J Card Imaging 15 1999 79 89
86. 201Tl defects Circulation 86 1992 1357 1369
87. R. Rohatgi, S. Epstein, J. Henriquez Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction Am J Cardiol 87 2001 1096 1099
88. R.C. Brunken, S. Kottou, C.A. Nienaber PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT Radiology 172 1989 65 73
89. M.F. DiCarli, F. Asgarzadie, H.R. Schelbert Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy Circulation 92 1995 3436 3444
90. R.O. Bonow The hibernating myocardium Implications for management of congestive heart failure Am J Cardiol 75 1995 17A 25A
91. K.S. Lee, T.H. Marwick, S.A. Cook Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization Circulation 90 1994 2687 2694
92. M.F. DiCarli, J. Davidson, R. Little Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction Am J Cardiol 73 1994 527 533
93. D. Eitzman, Z. Al-Aouar, H.L. Kanter Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography J Am Coll Cardiol 20 1992 559 565
94. J. Maddahi, A. Blitz, M. Phelps, H. Laks The use of positron emission tomography imaging in the management of patients with ischemic cardiomyopathy Adv Cardiol Surg 7 1996 163 188
95. G.D. Dreyfus, D. Duboc, A. Blasco Myocardial viability assessment in ischemic cardiomyopathy Benefits of coronary revascularization Ann Thorac Surg 57 1994 1402 1408
96. O. Akinboboye, O. Idris, P. Cannon Usefulness of positron emission tomography in defining myocardial viability in patients referred for cardiac transplantation Am J Cardiol 83 1999 1271 1274
97. J.J. Bax, J.A. Patton, D. Poldermans 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography cardiac applications Semin Nucl Med 30 2000 281 298
98. R.J. Gropler, E.M. Geltman, K. Sampathkumaran Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism J Am Coll Cardiol 20 1992 569 577
99. R.J. Gropler, B.A. Siegel, K. Sampathkumaran Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction J Am Coll Cardiol 19 1992 989 997
100. R.J. Gropler, E.M. Geltman, K. Sampathkumaran Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography J Am Coll Cardiol 22 1993 1587 1597
101. M.E. Shelton, C.S. Dence, D.R. Hwang Myocardial kinetics of fluorine-18 misonidazole a marker of hypoxic myocardium J Nucl Med 30 1989 351 358
102. M.E. Shelton, C.S. Dence, D.-R. Hwang In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography a potential approach for identification of jeopardized myocardium J Am Coll Cardiol 16 1990 477 485
103. R. Hoffmann, H. Lethen, T. Marwick Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms J Am Coll Cardiol 27 1996 330 336
104. I. Afridi, N.S. Kleiman, A.E. Raizner Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty Circulation 91 1995 663 670
105. J.H. Cornel, J.J. Bax, A. Elhendy Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease J Am Coll Cardiol 31 1998 1002 1010
106. I. Afridi, P.A. Grayburn, J.A. Panza Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction J Am Coll Cardiol 32 1998 921 926
107. R.O. Bonow Identification of viable myocardium Circulation 94 1996 2674 2680
108. H. Baumgartner, G. Porenta, Y. Lau Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT. Correlation with histopathology in explanted hearts J Am Coll Cardiol 32 1998 1701 1708
109. T. Laddis, W.J. Manning, P.G. Danias Cardiac MRI for assessment of myocardial perfusion current status and future perspectives J Nucl Cardiol 8 2001 207 214
110. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
111. P.R. Knuesel, D. Nanz, C. Wyss Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance. Relation to functional outcome after revascularization Circulation 108 2003 1095 1100
112. H.R. Schelbert Assessment of myocardial viability with positron emission tomography A.E. Iskandrian E.E. Van Der Wall Myocardial Viability ed 2 2000 Kluwer Academic Publishers Dordrecht, Boston, London 47 72
113. H. Samady, J.A. Elefteriades, B.G. Abbott Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome Circulation 100 1999 1298 1304
114. J.E. Udelson Steps forward in the assessment of myocardial viability in left ventricular dysfunction Circulation 97 1998 833 838
115. S.H. Rahimtoola Importance of diagnosing hibernating myocardium how and in whom? J Am Coll Cardiol 30 1997 1701 1706
116. J.G. Cleland, N. Freemantle, S.G. Ball The heart failure revascularisation trial (HEART) rationale, design and methodology Eur J Heart Fail 5 2003 295 303
117. J.S. Forrester, M.J. Price, R.R. Makkar Stem cell repair of infarcted myocardium. An overview for clinicians Circulation 108 2003 1139 1145
118. N.P. Fam, S. Verma, M. Kutryk Clinician guide to angiogenesis Circulation 108 2003 2613 2618